Search research articles
Contact Us
Filters
Showing results (141-150 of 152) with videos related to
Page
of 16
Sort By:
Journal of Biomedical Nanotechnology
|
March 3, 2011
Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats
Rudimar L Frozza, Andressa Bernardi, Karina Paese, et al.
Kidney International
|
April 14, 2006
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)
C Licht, S Heinen, M Józsi, et al.
Molecular Neurobiology
|
January 15, 2013
Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules
Rudimar L Frozza, Andressa Bernardi, Juliana B Hoppe, et al.
Neurobiology of Learning and Memory
|
August 20, 2013
Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway
Juliana B Hoppe, Karine Coradini, Rudimar L Frozza, et al.
Zeitschrift Fur Rheumatologie
|
April 26, 2018
[Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark]
T Häupl, A Skapenko, B Hoppe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 1999
Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy
M Mohr, E Hilgenfeld, T Fietz, et al.
Kidney International
|
January 25, 2007
The Uromodulin C744G mutation causes MCKD2 and FJHN in children and adults and may be due to a possible founder effect
M T F Wolf, B B Beck, F Zaucke, et al.
Clinical and Experimental Immunology
|
October 27, 2016
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders
C Wehling, O Amon, M Bommer, et al.
Klinische Padiatrie
|
January 29, 2011
Angiotensin II receptor blocker induced fetopathy: 7 cases
C Hünseler, A Paneitz, D Friedrich, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
|
April 25, 2012
Evidence that AKT and GSK-3β pathway are involved in acute hyperhomocysteinemia
Aline A da Cunha, Ana Paula Horn, Juliana B Hoppe, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 152) with videos related to
Sort By:
Page
of 16
Journal of Biomedical Nanotechnology
|
March 3, 2011
Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats
Rudimar L Frozza, Andressa Bernardi, Karina Paese, et al.
Kidney International
|
April 14, 2006
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)
C Licht, S Heinen, M Józsi, et al.
Molecular Neurobiology
|
January 15, 2013
Neuroprotective effects of resveratrol against Aβ administration in rats are improved by lipid-core nanocapsules
Rudimar L Frozza, Andressa Bernardi, Juliana B Hoppe, et al.
Neurobiology of Learning and Memory
|
August 20, 2013
Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway
Juliana B Hoppe, Karine Coradini, Rudimar L Frozza, et al.
Zeitschrift Fur Rheumatologie
|
April 26, 2018
[Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark]
T Häupl, A Skapenko, B Hoppe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 1999
Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy
M Mohr, E Hilgenfeld, T Fietz, et al.
Kidney International
|
January 25, 2007
The Uromodulin C744G mutation causes MCKD2 and FJHN in children and adults and may be due to a possible founder effect
M T F Wolf, B B Beck, F Zaucke, et al.
Clinical and Experimental Immunology
|
October 27, 2016
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders
C Wehling, O Amon, M Bommer, et al.
Klinische Padiatrie
|
January 29, 2011
Angiotensin II receptor blocker induced fetopathy: 7 cases
C Hünseler, A Paneitz, D Friedrich, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
|
April 25, 2012
Evidence that AKT and GSK-3β pathway are involved in acute hyperhomocysteinemia
Aline A da Cunha, Ana Paula Horn, Juliana B Hoppe, et al.
Page
of 16